๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The median survival time of first-line chemotherapy for advanced gastric ca...
Status
Recruiting
Location
Liu Ming
Start Date
2023-03-10
Trial ID
NCT05640609
Treatments Being Tested
SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06835179
Treatments Being Tested
The investigators propose to conduct a single-center, single-arm, Phase I c...
Status
Active Not Recruiting
Location
Colorectal Cancer, West China Hospital
Start Date
2025-02-21
Trial ID
NCT06865521
Treatments Being Tested
This prospective, single-arm study aims to investigate the efficacy and saf...
Status
Recruiting
Location
Shanghai Changzheng Hospital
Start Date
2023-05-01
Trial ID
NCT05585814
Treatments Being Tested
The purpose of this study is to identify patients who may be eligible to pa...
Status
Completed
Location
Miami Cancer Institute
Start Date
2021-12-14
Trial ID
NCT05158621
Basing on the strong evidence from former researches, patients with CRLM ca...
Status
Unknown
Location
Nanfang Hospital
Start Date
2018-07-16
Trial ID
NCT03686254
Treatments Being Tested
(1) To evaluate the oncological effects of Treatment of low locally advance...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-11-10
Trial ID
NCT06035133
Treatments Being Tested
This study is intended to confirm the long-term safety of ONO-4538 in pan-t...
Status
Recruiting
Location
Chiba Clinical Site1
Start Date
2020-09-10
Trial ID
NCT04566380
Treatments Being Tested
Immune checkpoint inhibitors have a poor effect on MSS colorectal cancer. S...
Status
Unknown
Location
Xianglin Yuan
Start Date
2022-07-01
Trial ID
NCT05438108
Treatments Being Tested
This is a non-randomized, open-label, dose-escalation, and dose-expansion P...
Status
Active Not Recruiting
Location
Cancer Hospital of Shandong First Medical University
Start Date
2025-03-13
Trial ID
NCT06771622